搜索筛选:
搜索耗时1.2171秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
类      型:
[期刊论文] 作者:Qian Sun,Li Wang,Hua-Yuan Zhu,, 来源:中华医学杂志(英文版) 年份:2019
Background:Serum antinuclear antibodies (ANAs) are positive in some patients with chronic lymphocytic leukemia (CLL),but the prognostic value of ANAs remains un...
[期刊论文] 作者:Rui JIANG,Jian-yong LI,Hua-yuan ZHU, 来源:当代医学科学(英文) 年份:2021
Chemoimmunotherapy(CIT)is defined as standard first line treatment for chronic lymphocytic leukemia(CLL)patients while patients with unfavorable biological char...
[会议论文] 作者:Yi Miao,Hua-Yuan Zhu,Lei Fan,Wei Xu,Jian-Yong Li, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Hua-Yuan Zhu,Wei Wu,Yuan Fu,Wen-Yi Shen,Peng Liu,Jian-Yong Li, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Bihui Pan,Hua-Yuan Zhu,Li Wang,Jin-Hua Liang,Xiao-Tong Li,Yi Xia,Jia-Zhu Wu,Lei Fan,Jian-Yong Li,Wei, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Bi-hui Pan,Jin Mao,Li Wang,Hua-Yuan Zhu,Jin-Hua Liang,Yi Xia,Jia-Zhu Wu,Lei Fan,Jian-Yong Li,Wei Xu, 来源:2019中国肿瘤学大会 年份:2019
[会议论文] 作者:Xiaohui Zhou,Jin-Hua Liang,Li Wang,Hua-Yuan Zhu,Jia-Zhu Wu,Yi Xia,Yue Li,Shu-Chao Qin,Lei Fan,Jian-Yong, 来源:2019中国肿瘤学大会 年份:2019
Objective Mantle cell lymphoma(MCL)is a distinct subtype of B cell non-Hodgkin lymphoma.No research has yet documented to investigate the prognostic implications of Epstein-Barr virus(EBV)infection in...
[会议论文] 作者:Qian Sun,Zhi-Yuan Qiu,Yan Wang,Man Wang,Li Wang,Yu-Jie Wu,Chun Qiao,Hua-Yuan Zhu,Wei Wu,Jia-Zhu Wu,Yi, 来源:2019中国肿瘤学大会 年份:2019
Objective Aggressive natural killer cell leukemia(ANKL)is an extraordinary rare aggressive malignancy of NK cells,but is relatively common in Asian....
[会议论文] 作者:Rui-Nan Lu,Yu Zhu,Hua-Yuan Zhu,Xiao-Yan Qu,Shuai Wang,Li Wang,Lei Fan,Wen-Yi Shen,Li-Juan Chen,Wei Xu, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Rui-Nan Lu,Yu Zhu,Hua-Yuan Zhu,Xiao-Yan Qu,Shuai Wang,Li Wang,Lei Fan,Wen-Yi Shen,Li-Juan Chen,Wei Xu, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: Many Chinese patients with hematologic diseases who need allogeneic hematopoietic stem cell transplantation(allo-HSCT) lack a human leukocyte antigen-matched donor.This retrospective study...
相关搜索: